Pre-clinical models of infectious diseases
Ended Awarded Last action
- Contract number
- HHSN272201700024I
- Awardee
-
Lovelace Biomedical And Environmental Research Institute, Inc. UEI N1UBCLRAPNG6 Part of Lovelace Biomedical Research Institute
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Task orders
- 2 $935,781 obligated
Award facts
- Opportunity
-
- NIHAI2016059 Solicitation number
- Pre-clinical models of infectious diseases Award Notice · Posted Apr 29, 2016
- Combined order value
-
- $935,781 Current, with exercised options
- $7,962,259 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 1% used
- $80,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 67 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute of Allergy and Infectious Diseases (NIAID) awarded an $80 million Indefinite Delivery Contract (IDC) to Lovelace Biomedical and Environmental Research Institute, Inc. (LBERI) for preclinical models of infectious diseases research from 2017 to 2024. LBERI, doing business as Inhalation Toxicology Research Institute, is a non-profit contract research organization that provides expertise in areas such as inhalation toxicology, infectious disease modeling, and medical countermeasure testing.
Under this multiple-award IDC, LBERI has received two task orders to date. The first, valued at $6,211.61, was for a kickoff meeting to initiate the base IDIQ contract. The second, a $7.9 million cost-plus-fixed-fee task order, directs LBERI to provide preclinical infectious disease modeling services in support of NIAID's research efforts. All work under the contract is performed in Albuquerque, New Mexico. This IDC supports NIAID's broader mission to conduct and support basic and applied research to better understand, treat, and ultimately prevent infectious diseases.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Pre-clinical models of infectious diseases task order B07 | National Institute of Allergy and Infectious Diseases (NIH) | $929,570 | |
| Task order a-08, "base IDIQ contract kick-off meeting | National Institute of Allergy and Infectious Diseases (NIH) | $6,212 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN272201700024I?
HHSN272201700024I was awarded to Lovelace Biomedical And Environmental Research Institute, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 13, 2017.
How much is contract HHSN272201700024I worth?
Orders under HHSN272201700024I have obligated $935,781. Their combined potential value, with all options, is $7,962,259. HHSN272201700024I's own ceiling is $80,000,000.
How many orders have been placed under contract HHSN272201700024I?
2 orders have been placed under HHSN272201700024I, the latest on July 1, 2020.
Who can order from contract HHSN272201700024I?
HHSN272201700024I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN272201700024I part of a contract vehicle?
Yes. HHSN272201700024I is part of NIAID Preclinical Models of Infectious Diseases 2017-2024.
Was contract HHSN272201700024I competed?
The extent of competition for HHSN272201700024I was full and open competition. The government received 67 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV